Vimarsana
Biggest News Aggregation in the World

Page 5 - Therapeutics Taskforce News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Therapeutics Taskforce. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Therapeutics Taskforce Today - Breaking & Trending Today

Indian variant still under investigation in UK, not yet of concern: PM - Vimarsana News

Indian variant still under investigation in UK, not yet of concern: PM

UK Prime Minister Boris Johnson was on Tuesday forced to defend what has been widely dubbed a delayed cancellation of his visit to India next week, which has been linked with the addition of India to the travel ban red list. Addressing a briefing at 10 Downing Street in London, he said the decision to add India to the red list was taken independently by the Joint Biosecurity Centre (JBC) on a precautionary basis because the so-called Indian variant of COVID-19 is yet to be classified as a variant of concern. He reiterated that the reason the 103 cases of the variant had been detected quick...

Government launches COVID-19 Antivirals Taskforce to roll out innovative home treatments this autumn - Vimarsana News

Government launches COVID-19 Antivirals Taskforce to roll out innovative home treatments this autumn

New Antivirals Taskforce could identify and deploy innovative COVID-19 treatments as early as autumn Treatments could be taken at home after a positive test or exposure to COVID-19 to reduce transmission and speed up recovery Drugs could help combat a rise in infections or new variants over the winter flu season A new Antivirals Taskforce has been launched by the government to identify treatments for UK patients who have been exposed to COVID-19 to stop the infection spreading and speed up recovery time. The taskforce will search for the most promising novel antiviral medicines that can be ta...

Source: gov.uk
Covid capsules to treat coronavirus at home could be ready by autumn, Boris Johnson says - Vimarsana News

Covid capsules to treat coronavirus at home could be ready by autumn, Boris Johnson says

Tuesday April 20, 2021, 5:47 PM Coronavirus capsules or tablets designed to treat Covid-19 at home could be ready as soon as autumn, the government has announced. Boris Johnson said he's launched a new Antivirals Taskforce to identify treatments for people exposed to the virus, which it is hoped could stop the infection spreading and speed up recovery time. It is hoped at least two effective treatments in "either in a tablet or capsule form" will be available this year. Health Secretary Matt Hancock said he hopes the government can "roll them out as soon as the autumn". Working in a similar ...

Source: itv.com
The FINANCIAL - Asthma Drug Shortens Recovery Time in COVID-19 Patients at Home - Vimarsana News

The FINANCIAL - Asthma Drug Shortens Recovery Time in COVID-19 Patients at Home

Share This The FINANCIAL --  Early treatment with an asthma drug budesonide shortens recovery time in COVID-19 patients aged over 50 who are treated at home or in other community settings. The Platform Randomised Trial of Interventions against COVID-19 in Older People (PRINCIPLE) trial is led by the University of Oxford. It is funded by UK Research and Innovation and the National Institute for Health Research (NIHR) through the COVID-19 Rapid Response rolling call. It is the world’s largest Phase 3 platform randomised controlled trial to find clear evidence of an effective COVID-19 treat...

Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19 - Vimarsana News

Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19

Date Time Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19 Inhaled budesonide, a common corticosteroid, is the first widely available, inexpensive drug found to shorten recovery times in COVID-19 patients aged over 50 who are treated at home and in other community settings, reports the UK’s PRINCIPLE trial in 1,779 participants. Early treatment with inhaled budesonide shortens recovery time by a median of three days in patients with COVID-19 who are at higher risk of more severe illness and are treated in the community, finds Oxford University’s Pla...